Insider Transactions in Q2 2023 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+0.7%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+0.5%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.48%
|
$17,100
$38.11 P/Share
|
|
Jun 30
2023
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+1.4%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
547
+0.97%
|
$20,786
$38.11 P/Share
|
|
Jun 30
2023
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
557
+0.09%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+1.55%
|
$21,166
$38.11 P/Share
|
|
Jun 08
2023
|
Karen Prange Director |
SELL
Open market or private sale
|
Direct |
713
-4.23%
|
$33,511
$47.89 P/Share
|
|
Jun 06
2023
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,422
-3.92%
|
$66,834
$47.03 P/Share
|
|
Jun 01
2023
|
Deborah Lee Yount Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,589
-5.4%
|
$116,505
$45.78 P/Share
|
|
May 31
2023
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
1,000
-0.17%
|
-
|
|
May 26
2023
|
Maggie Yuen Director |
SELL
Open market or private sale
|
Direct |
4,313
-47.95%
|
$202,711
$47.04 P/Share
|
|
May 25
2023
|
Robert S. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+3.88%
|
-
|
|
May 25
2023
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+15.9%
|
-
|
|
May 25
2023
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+26.16%
|
-
|
|
May 25
2023
|
Sven Wehrwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+13.07%
|
-
|
|
May 25
2023
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+8.0%
|
-
|
|
May 25
2023
|
Regina E Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+12.18%
|
-
|
|
May 25
2023
|
Maggie Yuen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+26.16%
|
-
|
|
May 01
2023
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,417
-10.84%
|
$194,348
$44.83 P/Share
|